159938 医药
已收盘 06-12 15:00:00
资讯
新帖
简况
【券商聚焦】中信建投证券首予劲方医药-B(02595)“买入”评级 指公司RAS靶向矩阵布局持续推进
金吾财讯 · 06-12 13:55
【券商聚焦】中信建投证券首予劲方医药-B(02595)“买入”评级 指公司RAS靶向矩阵布局持续推进
医药板块集体回升 科伦博泰生物(06990)涨7.20%、荣昌生物(09995)涨6.53%
金吾财讯 · 06-12 13:30
医药板块集体回升 科伦博泰生物(06990)涨7.20%、荣昌生物(09995)涨6.53%
金活医药集团(01110)：金辰医药与东莞市中医院就两款产品的研发订立谅解备忘录
智通财经 · 06-11 20:02
金活医药集团(01110)：金辰医药与东莞市中医院就两款产品的研发订立谅解备忘录
6月11日首药控股涨8.48%，鹏华医药科技股票A基金重仓该股
证券之星 · 06-11 16:25
6月11日首药控股涨8.48%，鹏华医药科技股票A基金重仓该股
楚天科技：目前专注于医药领域
证券之星 · 06-11 11:30
楚天科技：目前专注于医药领域
恒瑞医药三款新药获批临床，创新研发再添新进展｜医药早参
每日经济新闻 · 06-11 09:31
恒瑞医药三款新药获批临床，创新研发再添新进展｜医药早参
医药板块逆势走强，基本面有望持续改善，关注港股通创新药ETF易方达（159316）配置价值
证券之星 · 06-10
医药板块逆势走强，基本面有望持续改善，关注港股通创新药ETF易方达（159316）配置价值
拓新药业：新乡基地将继续承载公司原料药、医药中间体、功能食品原料产品生产、研发等核心业务
证券之星 · 06-10
拓新药业：新乡基地将继续承载公司原料药、医药中间体、功能食品原料产品生产、研发等核心业务
港股异动 | 先声药业(02096)午后涨超3% 近日与普祺医药就普美昔替尼凝胶订立独家推广服务协议
智通财经 · 06-10
港股异动 | 先声药业(02096)午后涨超3% 近日与普祺医药就普美昔替尼凝胶订立独家推广服务协议
港股异动 | 生物医药股逆市活跃，华昊中天医药-B暴涨逾40%
老虎资讯综合 · 06-10
港股异动 | 生物医药股逆市活跃，华昊中天医药-B暴涨逾40%
长春高新：公司全力聚焦医药创新与主业发展
证券之星 · 06-10
长春高新：公司全力聚焦医药创新与主业发展
港股收评：恒指跌，恒科涨；CPO概念爆发，半导体板块全天活跃，军工上涨；医药、石油石化、煤炭下跌；智谱大跌超13%，中国石油尾盘跌超4%
中新经纬 · 06-09
港股收评：恒指跌，恒科涨；CPO概念爆发，半导体板块全天活跃，军工上涨；医药、石油石化、煤炭下跌；智谱大跌超13%，中国石油尾盘跌超4%
6月8日海创药业跌7.50%，鹏华医药科技股票A基金重仓该股
证券之星 · 06-08
6月8日海创药业跌7.50%，鹏华医药科技股票A基金重仓该股
医药外包概念股全线走低 金斯瑞生物科技(01548)跌7.43%、药明生物(02269)跌7.39%
金吾财讯 · 06-08
医药外包概念股全线走低 金斯瑞生物科技(01548)跌7.43%、药明生物(02269)跌7.39%
上药益药医药（上海）有限公司成立
证券日报 · 06-08
上药益药医药（上海）有限公司成立
大型医药股表现活跃，指数逆势收涨，医药ETF易方达（512010）本周“吸金”超8亿元
证券之星 · 06-05
大型医药股表现活跃，指数逆势收涨，医药ETF易方达（512010）本周“吸金”超8亿元
6月5日悦康药业跌15.77%，富国医药创新股票A基金重仓该股
证券之星 · 06-05
6月5日悦康药业跌15.77%，富国医药创新股票A基金重仓该股
创胜集团医药-B(06628)建议委任徐汉森为非执行董事
智通财经 · 06-04
创胜集团医药-B(06628)建议委任徐汉森为非执行董事
差异化创新破局，科望医药领航免疫治疗新蓝海
格隆汇 · 06-04
差异化创新破局，科望医药领航免疫治疗新蓝海
楚天科技：将楚天打造成世界医药领军企业之一
证券之星 · 06-04
楚天科技：将楚天打造成世界医药领军企业之一
公司概况
公司名称：
--
所属市场：
上市日期：
--
主营业务：
发行价格：
--
{"stockData":{"symbol":"159938","market":"SZ","secType":"STK","nameCN":"医药","latestPrice":0.577,"timestamp":1781247798000,"preClose":0.566,"halted":0,"volume":77547900,"delay":0,"changeRate":0.0194,"floatShares":0,"shares":0,"eps":0,"marketStatus":"已收盘","change":0.011,"latestTime":"06-12 15:00:00","open":0.565,"high":0.579,"low":0.561,"amount":44259500,"amplitude":0.0318,"askPrice":0.578,"askSize":5971,"bidPrice":0.577,"bidSize":2578,"shortable":0,"etf":1,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1781487000000},"marketStatusCode":5,"adr":0,"adjPreClose":0.566,"symbolType":"fund","openAndCloseTimeList":[[1781227800000,1781235000000],[1781240400000,1781247600000]],"highLimit":0.623,"lowLimit":0.509,"ibTradeSell":false,"ibTradeBuySell":true,"isCdr":false,"pbRate":0,"committee":-0.156599,"marketValue":0,"turnoverRate":0,"status":0,"nextConnectDate":"根据港交所公布的数据，今日已停止北向交易，下一个交易日为北京时间 2026-06-15。","floatMarketCap":0},"requestUrl":"/m/hq/s/159938/wiki","defaultTab":"wiki","newsList":[{"id":"2642354252","title":"【券商聚焦】中信建投证券首予劲方医药-B(02595)“买入”评级 指公司RAS靶向矩阵布局持续推进","url":"https://stock-news.laohu8.com/highlight/detail?id=2642354252","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2642354252?lang=zh_cn&edition=full","pubTime":"2026-06-12 13:55","pubTimestamp":1781243717,"startTime":"0","endTime":"0","summary":"金吾财讯 | 中信建投证券发布研报指，劲方医药-B 两项研究成果入选2026年ASCO年会，其中GFH375在KRAS G12D突变胆管癌及结直肠癌后线患者中显示初步疗效，GFS202A I期数据支持GDF15/IL-6双靶向改善肿瘤恶病质的可行性。公司RAS靶向矩阵与恶病质差异化布局持续推进，首次覆盖给予“买入”评级，未给出目标价。安全性方面，GFH375在合计61例患者中≥3级TRAE发生率31.1%，TRAE导致治疗终止比例3.3%，未观察到新的安全信号。首次覆盖，给予“买入”评级。","market":"fut","thumbnail":"https://static.szfiu.com/news/20250106/ZDQ3YWRiNzU2MjI5OWUwYTllMmZlMTAyNzEyNzQzMTU2MQ==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250106/ZDQ3YWRiNzU2MjI5OWUwYTllMmZlMTAyNzEyNzQzMTU2MQ==.jpg"],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1983634","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09939","02595","159938"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642254781","title":"医药板块集体回升 科伦博泰生物(06990)涨7.20%、荣昌生物(09995)涨6.53%","url":"https://stock-news.laohu8.com/highlight/detail?id=2642254781","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2642254781?lang=zh_cn&edition=full","pubTime":"2026-06-12 13:30","pubTimestamp":1781242214,"startTime":"0","endTime":"0","summary":"金吾财讯 | 港股医药板块集体回升，科伦博泰生物 涨7.20%，荣昌生物涨6.53%，康诺亚-B涨5.58%，复宏汉霖涨5.36%，康方生物涨5.07%，君实生物涨4.61%，药明合联涨4.06%，诺诚健华涨3.96%。英伟达同时为 Abridge 投资方，新模型基于英伟达开放模型套件 Nemotron 训练，Abridge 将采用去标识化临床数据进行定制优化，预计 2026 年晚些时候上线。东莞证券研报认为，受行业合规整顿以及消费疲软等因素影响，2025年医药生物行业整体归母净利润同比有所下滑。","market":"us","thumbnail":"https://static.szfiu.com/news/20241108/OWU0MGRiNDM1NDA5NTM4MzU5OQ==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/OWU0MGRiNDM1NDA5NTM4MzU5OQ==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1983673","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014674.SGD","09995","LU0417516571.SGD","02162","LU2399975544.HKD","02268","LU0348766576.USD","LU0348735423.USD","LU0417516738.SGD","688331","LU0348827113.USD","LU0417516902.SGD","LU0348825331.USD","LU1064130708.USD","LU0348784397.USD","BK1161","LU2328871848.SGD","HK0000320223.HKD","09939","LU2148510915.USD","02696","159938","LU1794554557.SGD","LU2476274308.USD","09969","BK0239","HK0000306701.USD","HK0000320264.USD","LU0348767384.USD","LU0540923850.HKD","LU2488822045.USD","BK1587","BK1515","HK0000306685.HKD","LU1720050803.USD","06990","01877","LU0348783233.USD","LU1961090484.USD","LU2476274720.SGD","IE00BPRC5H50.USD","BK1583","HK0000165453.HKD","LU0561508036.HKD","LU0634319403.HKD","LU1064131003.USD","BK1141","BK1574","LU1969619763.USD","09926"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642281453","title":"金活医药集团(01110)：金辰医药与东莞市中医院就两款产品的研发订立谅解备忘录","url":"https://stock-news.laohu8.com/highlight/detail?id=2642281453","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2642281453?lang=zh_cn&edition=full","pubTime":"2026-06-11 20:02","pubTimestamp":1781179376,"startTime":"0","endTime":"0","summary":"智通财经APP讯，金活医药集团(01110)发布公告，于2026年6月11日，公司的关连人士金辰医药有限公司(金辰)已与广州中医药大学东莞医院(东莞市中医院)就产品“紫珠叶洗剂”及“加味天麻健脑方”的研发订立谅解备忘录。各方拟就产品“紫珠叶洗剂”及“加味天麻健脑方”的临床研究、监管注册及商业化开展合作。于2026年6月11日，公司关连人士金辰已与公司订立谅解备忘录，据此，金辰拟委任公司及╱或其全资附属公司为产品“紫珠叶洗剂”及“加味天麻健脑方”的唯一及独家分销商。建议分销将涵盖产品“紫珠叶洗剂”及“加味天麻健脑方”于中国香港、中国内地及跨境电子商务渠道的分销。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1453333.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","09939","BK1197","BK1515","01110","159938","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642940792","title":"6月11日首药控股涨8.48%，鹏华医药科技股票A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2642940792","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2642940792?lang=zh_cn&edition=full","pubTime":"2026-06-11 16:25","pubTimestamp":1781166322,"startTime":"0","endTime":"0","summary":"证券之星消息，6月11日首药控股涨8.48%，收盘报34.42元，换手率3.71%，成交量2.37万手，成交额7785.23万元。重仓首药控股的前十大公募基金请见下表：根据2026基金Q1季报公募基金重仓股数据，重仓该股的公募基金共10家，其中持有数量最多的公募基金为鹏华基金的鹏华医药科技股票A。鹏华医药科技股票A的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026061100025337.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1161","09939","BK1574","159938","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642403672","title":"楚天科技：目前专注于医药领域","url":"https://stock-news.laohu8.com/highlight/detail?id=2642403672","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2642403672?lang=zh_cn&edition=full","pubTime":"2026-06-11 11:30","pubTimestamp":1781148638,"startTime":"0","endTime":"0","summary":"证券之星消息，楚天科技(300358)06月10日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘您好，公司旗下楚天净邦从事洁净室系统工程业务，请问近年来该板块业务拓展及订单落地成效如何？除医药领域外，公司是否有计划将洁净室业务向半导体、微电子、新能源等蓝海领域延伸布局？如有，目前处于何种阶段？谢谢！楚天科技回复：您好！目前专注于医药领域，谢谢！本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026061100014621.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","BK1161","159938","BK1515","BK0061","BK1574","09939","BK0077","BK0028","300358"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642470626","title":"恒瑞医药三款新药获批临床，创新研发再添新进展｜医药早参","url":"https://stock-news.laohu8.com/highlight/detail?id=2642470626","media":"每日经济新闻","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2642470626?lang=zh_cn&edition=full","pubTime":"2026-06-11 09:31","pubTimestamp":1781141460,"startTime":"0","endTime":"0","summary":"截至6月10日收盘，市场全天震荡调整，沪深两市成交额2.62万亿元。医药ETF（512120）上涨1.53%，港股通生物科技ETF（159102）上涨1.40%。相关个股中，恒瑞医药上涨1.36%、药明康德上涨3.81%、片仔癀上涨0.46%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202606113767626750.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202606113767626750.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK0239","LU0359202008.SGD","LU2097828805.USD","LU1023057109.AUD","LU1781817850.SGD","LU2580892789.USD","BK1574","LU1255011170.USD","BK1515","LU2543165471.USD","LU1064130708.USD","BK0060","09939","LU2148510915.USD","BK1191","LU1064131003.USD","LU1820825898.SGD","LU1997245177.USD","LU2097828631.EUR","159938","LU0359201612.USD","BK0028","LU2495084118.USD","BK0012","BK0188","LU0359201885.HKD","LU0405327494.USD","LU2097828474.EUR","LU2097828557.USD","BK0183","LU1997244956.HKD","LU0405327148.USD","LU2580892862.HKD","LU2328871848.SGD","LU1969619763.USD","LU2289578879.USD","LU1580142542.USD","600276","LU2488822045.USD","01276","LU1328615791.USD","LU2097828714.EUR","LU1146622755.USD","LU1997245094.SGD","BK1161","BK0196","LU1655091616.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642428491","title":"医药板块逆势走强，基本面有望持续改善，关注港股通创新药ETF易方达（159316）配置价值","url":"https://stock-news.laohu8.com/highlight/detail?id=2642428491","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2642428491?lang=zh_cn&edition=full","pubTime":"2026-06-10 19:04","pubTimestamp":1781089491,"startTime":"0","endTime":"0","summary":"6月10日，医药板块主要指数逆势上涨，截至收盘，恒生港股通创新药指数上涨2.0%，中证港股通医药卫生综合指数上涨1.5%，中证创新药产业指数上涨1.8%，中证生物科技主题指数上涨1.0%，沪深300医药卫生指数上涨1.6%。从估值维度看，经过这一轮调整，港股创新药板块估值已有所回落，沪深300医药指数也处于近10年历史较低分位。此外，A股创新药板块一季度收入同比增长26.4%，多家生物科技公司已实现扭亏为盈，基本面有望持续改善。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://fund.stockstar.com/SS2026061000035676.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1161","159316","BK1515","BK1574","516080","159938","09939"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642443135","title":"拓新药业：新乡基地将继续承载公司原料药、医药中间体、功能食品原料产品生产、研发等核心业务","url":"https://stock-news.laohu8.com/highlight/detail?id=2642443135","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2642443135?lang=zh_cn&edition=full","pubTime":"2026-06-10 15:00","pubTimestamp":1781074851,"startTime":"0","endTime":"0","summary":"证券之星消息，拓新药业06月09日在投资者关系平台上答复投资者关心的问题。公司前次募集资金投资项目均已完成，新乡基地将继续承载公司原料药、医药中间体、功能食品原料产品生产、研发等核心业务。通过优化产能布局，实现新乡与内蒙古两大基地的协同互补，有利于提升整体核心竞争力。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026061000021133.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1574","BK1161","BK1515","BK0239","159938","301089","09939"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642108254","title":"港股异动 | 先声药业(02096)午后涨超3% 近日与普祺医药就普美昔替尼凝胶订立独家推广服务协议","url":"https://stock-news.laohu8.com/highlight/detail?id=2642108254","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2642108254?lang=zh_cn&edition=full","pubTime":"2026-06-10 13:39","pubTimestamp":1781069998,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，先声药业(02096)午后涨超3%，截至发稿，涨3.03%，报9.87港元，成交额4009.82万港元。消息面上，近日，先声药业发布公告，本集团与北京普祺医药科技股份有限公司(普祺医药)就普美昔替尼凝胶订立独家推广服务协议(该协议)。根据该协议，本集团将获得普美昔替尼凝胶在中国内地、香港及澳门所有皮肤病领域适应症的独家推广权益。目前，普美昔替尼凝胶成人与青少年特应性皮炎(AD)适应症新药上市申请(NDA)已获国家药品监督管理局药品审评中心(CDE)受理。本次合作将进一步强化本集团在自身免疫领域的产品布局。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1452434.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1191","BK1583","BK4588","VXUS","09939","BK1515","BK4585","02096","BK1161","159938","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1152361325","title":"港股异动 | 生物医药股逆市活跃，华昊中天医药-B暴涨逾40%","url":"https://stock-news.laohu8.com/highlight/detail?id=1152361325","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1152361325?lang=zh_cn&edition=full","pubTime":"2026-06-10 11:36","pubTimestamp":1781062600,"startTime":"0","endTime":"0","summary":"6月10日，港股生物医药股逆市活跃，$华昊中天医药-B(02563)$暴涨逾40%，$迈威生物-B(02493)$涨逾23%，$宜明昂科-B(01541)$涨逾8%，$银诺医药-B(02591)$、$泰格医药(03347)$、$科伦博泰生物(06990)$、药明康德跟涨。","market":"hk","thumbnail":"https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"1f496bb5e04e0670aba492129df4bfd4","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XBI","159938","BK1574","BK4585","BK1515","BK4588","VXUS","BK1161","09939","BK4581","02563","161726"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642678416","title":"长春高新：公司全力聚焦医药创新与主业发展","url":"https://stock-news.laohu8.com/highlight/detail?id=2642678416","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2642678416?lang=zh_cn&edition=full","pubTime":"2026-06-10 08:57","pubTimestamp":1781053033,"startTime":"0","endTime":"0","summary":"证券之星消息，长春高新(000661)06月10日在投资者关系平台上答复投资者关心的问题。投资者提问：请问公司会尽快剥离房地产业务吗？长春高新回复：您好，感谢您对公司的关注，，公司全力聚焦医药创新与主业发展，同时也正推进辅业轻资产转型；同时，未来地产板块如有其他达到信息披露标准的情况，公司会按照法律法规要求履行披露义务，谢谢！本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。相关 ETF","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026061000007776.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159938","09939","BK0057","000661","BK1161","BK0046","BK0075","BK0188","BK0239","BK1515","BK1574","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642468767","title":"港股收评：恒指跌，恒科涨；CPO概念爆发，半导体板块全天活跃，军工上涨；医药、石油石化、煤炭下跌；智谱大跌超13%，中国石油尾盘跌超4%","url":"https://stock-news.laohu8.com/highlight/detail?id=2642468767","media":"中新经纬","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2642468767?lang=zh_cn&edition=full","pubTime":"2026-06-09 16:12","pubTimestamp":1780992720,"startTime":"0","endTime":"0","summary":"9日，港股主要指数走势分化，恒生科技指数盘中涨超1%。截至收盘，恒指跌0.37%，恒生科技指数涨0.29%。盘面上，硬件设备、半导体、造纸、建材、环保、军工等板块上涨。CPO概念股活跃，长飞光纤光缆盘中涨超10%。石油石化、煤炭、医药、交运、地产等板块跌幅居前；CRO、汽车电子、港口运输等概念走低。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202606093765131790.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["SOXQ","BNO","SHLD","USE","PXJ","GUSH","DIG","02513","XES","SOXS","SOXY","USD","OILT","OILU","DBC","DRLL","PXE","SMH","OILK","VXUS","WTIU","VDE","SSG","FTXN","SMHX","SOXX","IXC","CHPS","XLE","CHPY","IEO","USOI","161032","09939","161024","159019","FTXL","USL","HSI","PSI","DBE","SOXL","TEKX","OIH","DRIP","XOP","159938","VGT","ERX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641210764","title":"6月8日海创药业跌7.50%，鹏华医药科技股票A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2641210764","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2641210764?lang=zh_cn&edition=full","pubTime":"2026-06-08 16:43","pubTimestamp":1780908209,"startTime":"0","endTime":"0","summary":"证券之星消息，6月8日海创药业跌7.50%创60日新低，收盘报34.88元，换手率2.57%，成交量2.55万手，成交额9016.46万元。重仓海创药业的公募基金请见下表：根据2026基金Q1季报公募基金重仓股数据，重仓该股的公募基金共3家，其中持有数量最多的公募基金为鹏华基金的鹏华医药科技股票A。鹏华医药科技股票A的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060800022208.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1161","BK1515","09939","BK1574","159938"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641105779","title":"医药外包概念股全线走低 金斯瑞生物科技(01548)跌7.43%、药明生物(02269)跌7.39%","url":"https://stock-news.laohu8.com/highlight/detail?id=2641105779","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2641105779?lang=zh_cn&edition=full","pubTime":"2026-06-08 13:43","pubTimestamp":1780897412,"startTime":"0","endTime":"0","summary":"中邮证券表示，2026年第一季度，海外CXO行业整体呈现分化复苏格局，全球生物制药融资环境出现实质性改善，带动需求逐步回暖，但早期初创企业资金压力仍未完全缓解，不同细分赛道、不同规模企业的表现存在差异，行业结构性分化特征进一步凸显。展望2026年，海外头部CXO企业收入指引仍维持稳健小幅增长格局，叠加全球生物医药投融资逐步回暖、创新药研发需求稳步复苏，行业景气度延续上行态势，成长确定性进一步增强。","market":"nz","thumbnail":"https://static.szfiu.com/news/20250110/NDE0ZmVkNmQ0OWQ1YWQ5ZWU5ODBlOTBjYzlmMjcxMzI0MDU1NzE=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250110/NDE0ZmVkNmQ0OWQ1YWQ5ZWU5ODBlOTBjYzlmMjcxMzI0MDU1NzE=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1983281","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02269","03347","BK1574","BK1515","LU0516422440.USD","09939","LU0856984785.SGD","BK1191","LU0708995583.HKD","01873","HK0000306685.HKD","LU2045819591.USD","LU2039709279.SGD","SG9999002463.SGD","159938","LU0039217434.USD","LU0348766576.USD","06821","LU0348767384.USD","LU0359201612.USD","BK1521","LU0326950275.SGD","LU0348735423.USD","LU1880383366.USD","LU0320764599.SGD","01521","LU0456827905.SGD","LU0417516902.SGD","LU3063872942.SGD","06127","HK0000320264.USD","LU0516422366.SGD","LU0572944931.SGD","LU0516423091.SGD","LU0140636845.USD","01548","BK1141","LU1046422090.SGD","HK0000320223.HKD","02359","LU2242644610.SGD","LU1688375341.USD","LU0417516738.SGD","LU0588546209.SGD","LU0051755006.USD","03759","BK1589","LU0307460666.USD","LU1720050803.USD","LU0516422952.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641106434","title":"上药益药医药（上海）有限公司成立","url":"https://stock-news.laohu8.com/highlight/detail?id=2641106434","media":"证券日报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2641106434?lang=zh_cn&edition=full","pubTime":"2026-06-08 13:36","pubTimestamp":1780896960,"startTime":"0","endTime":"0","summary":"企查查APP显示，近日，上药益药医药（上海）有限公司成立，法定代表人为顾斌，注册资本为8亿元，经营范围包含：第一类医疗设备租赁；机械设备租赁；仓储设备租赁服务；数字创意产品展览展示服务等。企查查股权穿透显示，该公司由上海医药（601607）全资子公司上药控股有限公司、上海医药大健康云商股份有限公司共同持股。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202606083763482714.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1161","BK1574","159938","BK1515","09939"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641411787","title":"大型医药股表现活跃，指数逆势收涨，医药ETF易方达（512010）本周“吸金”超8亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2641411787","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2641411787?lang=zh_cn&edition=full","pubTime":"2026-06-05 19:13","pubTimestamp":1780658013,"startTime":"0","endTime":"0","summary":"截至收盘，沪深300医药卫生指数上涨0.8%，中证生物科技主题指数上涨0.1%，中证创新药产业指数下跌0.02%，中证港股通医药卫生综合指数下跌0.8%，恒生港股通创新药指数下跌1.5%。Wind数据显示，医药ETF易方达(512010，联接基金A/C：001344/007883)本周前四个交易日连续获资金净流入，合计超8亿元。中信建投研报表示，医疗器械行业将迎来业绩修复和估值重塑。中国器械企业龙头持续创新、出海、并购，有望成长为全球医疗器械龙头，行业成长逻辑已从国产替代拓展到国际化和技术创新，估值迎来重塑机遇。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://fund.stockstar.com/SS2026060500035074.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1515","512010","BK1574","159938","09939","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641115053","title":"6月5日悦康药业跌15.77%，富国医药创新股票A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2641115053","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2641115053?lang=zh_cn&edition=full","pubTime":"2026-06-05 16:38","pubTimestamp":1780648713,"startTime":"0","endTime":"0","summary":"证券之星消息，6月5日悦康药业跌15.77%创60日新低，收盘报13.73元，换手率8.54%，成交量38.41万手，成交额5.46亿元。重仓悦康药业的公募基金请见下表：根据2026基金Q1季报公募基金重仓股数据，重仓该股的公募基金共7家，其中持有数量最多的公募基金为富国基金的富国医药创新股票A。富国医药创新股票A的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060500028298.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1161","BK0239","09939","688658","BK1515","159938","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640815443","title":"创胜集团医药-B(06628)建议委任徐汉森为非执行董事","url":"https://stock-news.laohu8.com/highlight/detail?id=2640815443","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640815443?lang=zh_cn&edition=full","pubTime":"2026-06-04 19:21","pubTimestamp":1780572110,"startTime":"0","endTime":"0","summary":"智通财经APP讯，创胜集团医药-B 发布公告，徐汉森博士(徐博士)将获委任为非执行董事;及包骏博士(包博士)将获委任为独立非执行董事，惟均须待本公司股东于将于2026年6月30日召开的股东周年大会上批准后，方可作实。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1450290.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1515","159938","06628","09939","BK1574","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640153649","title":"差异化创新破局，科望医药领航免疫治疗新蓝海","url":"https://stock-news.laohu8.com/highlight/detail?id=2640153649","media":"格隆汇","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640153649?lang=zh_cn&edition=full","pubTime":"2026-06-04 16:41","pubTimestamp":1780562506,"startTime":"0","endTime":"0","summary":"当行业竞相追逐成熟靶点时，科望医药选择了更具挑战的源头创新之路，瞄准下一代免疫疗法，成为全球MCE赛道为数不多的定义者与领跑者。","market":"sg","thumbnail":"https://img2.gelonghui.com/d273d-c4393547-47e6-485a-a81d-c0fea64e5b84.jpg?guru_height=855&guru_width=1280&guru_size=118253","type":0,"news_type":0,"thumbnails":["https://img2.gelonghui.com/d273d-c4393547-47e6-485a-a81d-c0fea64e5b84.jpg?guru_height=855&guru_width=1280&guru_size=118253"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/p/5064974","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"gelonghui_highlight","symbols":["BK1161","159938","09939","BK1515","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640587161","title":"楚天科技：将楚天打造成世界医药领军企业之一","url":"https://stock-news.laohu8.com/highlight/detail?id=2640587161","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640587161?lang=zh_cn&edition=full","pubTime":"2026-06-04 16:24","pubTimestamp":1780561450,"startTime":"0","endTime":"0","summary":"证券之星消息，楚天科技(300358)06月04日在投资者关系平台上答复投资者关心的问题。投资者提问：公司在多次访谈中提到'十五五'期间向百亿级企业迈进，请问公司十五五的总体目标是什么？有没有具体的量化目标？谢谢。楚天科技回复：您好！总体目标系将楚天打造成世界医药领军企业之一，谢谢！本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060400027690.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1515","300358","159938","BK0251","BK1161","BK1574","BK0061","BK0077","BK0028","09939"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1781400645744,"stockEarnings":[{"period":"1week","weight":0.0052},{"period":"1month","weight":-0.0998},{"period":"3month","weight":-0.0942},{"period":"6month","weight":-0.1349},{"period":"1year","weight":-0.1258},{"period":"ytd","weight":-0.1109}],"compareEarnings":[{"period":"1week","weight":0.0009},{"period":"1month","weight":-0.0497},{"period":"3month","weight":-0.0156},{"period":"6month","weight":0.0366},{"period":"1year","weight":0.1848},{"period":"ytd","weight":0.0158}],"compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.43.1","shortVersion":"4.43.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"医药(159938)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供医药(159938)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"医药,159938,医药股票,医药股票老虎,医药股票老虎国际,医药行情,医药股票行情,医药股价,医药股市,医药股票价格,医药股票交易,医药股票购买,医药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"医药(159938)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供医药(159938)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}